SCHEMBL15026136

SCHEMBL15026136

COC(=O)c1scc(C#N)c1NC(=O)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 4/20 0.39
PKM P14618 1/20 0.39
ATM Q13315 1/20 0.39
KDM4E B2RXH2 5/20 0.37
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 2/20 0.37
POLB P06746 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 1/20 0.37
PABPC1 P11940 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
HTR1A P08908 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
MAPK8 P45983 1/20 0.35
MAPK9 P45984 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL613613 0.81 MAPT (0.58) MAPTPKMATMKDM4ECYP1A2
SCHEMBL12429306 0.79 NPSR1 (0.49) NPSR1MAPTPKMATMKDM4E
SCHEMBL12429290 0.74 NPSR1 (0.36) NPSR1MAPTKDM4ECYP1A2CYP3A4
SCHEMBL18430438 0.72 NPSR1 (0.43) NPSR1MAPTPKMATMKDM4E
SCHEMBL4166271 0.72 KMT2A (0.37) NPSR1MAPTPKMATMKDM4E
SCHEMBL23460281 0.71 MAPT (0.41) MAPTPKMATMKDM4ECYP1A2
SCHEMBL9097371 0.71 KDM4E (0.53) NPSR1MAPTATMKDM4EPOLB
SCHEMBL31062589 0.70 ALDH1A1 (0.60) NPSR1MAPTCYP1A2CYP3A4POLB
SCHEMBL612157 0.68 NPC1 (0.63) NPSR1MAPTPKMATMKDM4E
SCHEMBL11103591 0.68 HSD17B10 (0.36) NPSR1MAPTATMKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication MED1, ZC3HAV1, BET1 NPSR1 2458/4885MAPT 2354/4885PKM 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.